Concepedia

Author

Jaya Goswami

Moderna Therapeutics (United States)

Also Known As

Jaya Goswami

17

Publications

967

Citations

9

H-Index

5

Concepts

All Affiliations

Moderna Therapeutics (United States)nLIGHT (United States)University of Maryland, BaltimoreNational Center for Global Health and MedicineJohns Hopkins University
JG

About

Jaya Goswami is an author at Moderna Therapeutics (United States) specializing in maternal health, malaria, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

51

2

Public Health

1

1

51

3

Global Health

1

1

51

4

Malaria

1

1

51

5

Maternal Health

1

1

51

Jaya Goswami

×

9

Publications

949

Citations

9

H-Index

YearCitations

Efficacy and Safety of an mRNA-Based RSV PreF Vaccine in Older Adults

Eleanor Wilson, Jaya Goswami, Abdullah H Baqui,

New England Journal of Medicine

2023

379

Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes

Fang Shen, Zihua Hu, Jaya Goswami,

Journal of Biological Chemistry

2006

290

A bone‐protective role for IL‐17 receptor signaling in ovariectomy‐induced bone loss

Jaya Goswami, Nydiaris Hernández‐Santos, Luis Zúñiga,

European Journal of Immunology

2009

84

Chloroquine as weekly chemoprophylaxis or intermittent treatment to prevent malaria in pregnancy in Malawi: a randomised controlled trial

Titus Divala, Randy G. Mungwira, Patricia Mawindo,

The Lancet Infectious Diseases

2018

51

Safety and Immunogenicity of an mRNA-Based RSV Vaccine Including a 12-Month Booster in a Phase 1 Clinical Trial in Healthy Older Adults

Christine A. Shaw, Brandon Essink, Charles Harper,

The Journal of Infectious Diseases

2024

50

Humoral Immunogenicity of mRNA-1345 RSV Vaccine in Older Adults

Jaya Goswami, Abdullah H Baqui, Pablo Alexis Doreski,

The Journal of Infectious Diseases

2024

34

Immunization Coverage Surveys and Linked Biomarker Serosurveys in Three Regions in Ethiopia

Mark A. Travassos, Berhane Beyene, Zenaw Adam,

PLoS ONE

2016

31

Safety and immunogenicity of mRNA-1345 RSV vaccine coadministered with an influenza or COVID-19 vaccine in adults aged 50 years or older: an observer-blinded, placebo-controlled, randomised, phase 3 trial

Jaya Goswami, José F. Cardona, Denise C. Hsu,

The Lancet Infectious Diseases

2024

20

Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial

Chong Ma, Jiejun Du, Lan Lan,

Nature Communications

2025

10

Page 1